Stock DCP DIS-CHEM PHARMACIES LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Dis-Chem Pharmacies Limited

Equities

DCP

ZAE000227831

Drug Retailers

End-of-day quote Johannesburg S.E.
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
32.54 ZAR +5.62% Intraday chart for Dis-Chem Pharmacies Limited +4.63% +6.03%
Feb. 23 South Africa's Dis-Chem sales rise 12.2% on strong retail revenue RE
Feb. 23 Dis-Chem Pharmacies Limited Announces Group Revenue Results for the Period from 1 September 2023 to 28 January 2024 CI

Valuation

Fiscal Period: February 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 22,190 18,595 19,254 29,767 23,265 27,961 - -
Enterprise Value (EV) 1 23,832 21,842 23,190 33,569 27,952 31,085 30,338 29,398
P/E ratio 30.2 x 31.1 x 28.8 x 34.9 x 23.3 x 28.1 x 22 x 18.9 x
Yield 1.33% 0.59% 1.39% 1.15% 1.72% 1.41% 1.85% 2.2%
Capitalization / Revenue 1.04 x 0.78 x 0.73 x 0.98 x 0.71 x 0.78 x 0.7 x 0.63 x
EV / Revenue 1.11 x 0.91 x 0.88 x 1.1 x 0.86 x 0.86 x 0.76 x 0.67 x
EV / EBITDA 17 x 12 x 11.8 x 14 x 10.2 x 10.9 x 9.03 x 7.73 x
EV / FCF - 24.4 x 32.1 x - -118 x 17.2 x 17.3 x 15.3 x
FCF Yield - 4.09% 3.12% - -0.84% 5.82% 5.77% 6.54%
Price to Book 10.5 x 8.04 x 6.53 x 8.8 x 5.92 x 6.19 x 5.3 x 4.54 x
Nbr of stocks (in thousands) 860,084 860,084 859,553 859,829 860,084 859,269 - -
Reference price 2 25.80 21.62 22.40 34.62 27.05 32.54 32.54 32.54
Announcement Date 5/16/19 5/20/20 5/21/21 5/23/22 5/18/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: February 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 21,420 23,984 26,278 30,407 32,664 36,013 39,889 44,189
EBITDA 1 1,404 1,824 1,971 2,394 2,746 2,851 3,360 3,803
EBIT 1 1,218 1,248 1,266 1,539 1,744 1,772 2,154 2,455
Operating Margin 5.69% 5.21% 4.82% 5.06% 5.34% 4.92% 5.4% 5.56%
Earnings before Tax (EBT) 1 1,056 868.8 940.9 1,227 1,417 1,428 1,740 2,002
Net income 1 734.7 598.2 668.7 853.4 1,000 987.9 1,278 1,476
Net margin 3.43% 2.49% 2.54% 2.81% 3.06% 2.74% 3.2% 3.34%
EPS 2 0.8540 0.6960 0.7780 0.9920 1.163 1.158 1.479 1.725
Free Cash Flow 1 - 893.6 722.9 - -236 1,809 1,752 1,922
FCF margin - 3.73% 2.75% - -0.72% 5.02% 4.39% 4.35%
FCF Conversion (EBITDA) - 48.99% 36.68% - - 63.44% 52.13% 50.55%
FCF Conversion (Net income) - 149.38% 108.1% - - 183.11% 137.1% 130.29%
Dividend per Share 2 0.3420 0.1280 0.3110 0.3970 0.4660 0.4590 0.6026 0.7165
Announcement Date 5/16/19 5/20/20 5/21/21 5/23/22 5/18/23 - - -
1ZAR in Million2ZAR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: February 2020 S1 2020 S2 2021 S1 2021 S2 2022 S1 2023 S1
Net sales 11,848 12,137 12,807 13,471 14,936 -
EBITDA - - - - - -
EBIT - - - - - -
Operating Margin - - - - - -
Earnings before Tax (EBT) 388.1 - - - - -
Net income 1 - - - - - 602.5
Net margin - - - - - -
EPS 2 0.3100 0.3860 0.3600 0.4180 0.4840 0.7000
Dividend per Share - - - - - -
Announcement Date 11/7/19 5/20/20 11/5/20 5/21/21 11/3/21 9/30/22
1ZAR in Million2ZAR
Estimates

Balance Sheet Analysis

Fiscal Period: February 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,641 3,247 3,936 3,802 4,687 3,124 2,377 1,437
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.169 x 1.78 x 1.997 x 1.588 x 1.707 x 1.096 x 0.7076 x 0.3779 x
Free Cash Flow 1 - 894 723 - -236 1,809 1,752 1,923
ROE (net income / shareholders' equity) 40.1% 28.9% 25.9% 27.4% 27.7% 23.2% 25.5% 25.5%
ROA (Net income/ Total Assets) - 5.67% 5.63% - 6.76% 6.22% 7.67% 8.3%
Assets 1 - 10,554 11,885 - 14,796 15,892 16,663 17,785
Book Value Per Share 2 2.450 2.690 3.430 3.940 4.570 5.250 6.140 7.160
Cash Flow per Share 2 1.070 - - 1.600 0.9900 1.910 2.590 3.120
Capex 1 395 363 401 377 1,090 971 907 928
Capex / Sales 1.84% 1.51% 1.53% 1.24% 3.34% 2.7% 2.27% 2.1%
Announcement Date 5/16/19 5/20/20 5/21/21 5/23/22 5/18/23 - - -
1ZAR in Million2ZAR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Dis-Chem Pharmacies Limited

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
32.54 ZAR
Average target price
30 ZAR
Spread / Average Target
-7.81%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
DIS-CHEM PHARMACIES LIMITED Stock Dis-Chem Pharmacies Limited
+6.03% 1.49B
WALGREENS BOOTS ALLIANCE, INC. Stock Walgreens Boots Alliance, Inc.
-32.21% 15.27B
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.31% 3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. DCP Stock
  4. Financials Dis-Chem Pharmacies Limited